Zobrazeno 1 - 10
of 43
pro vyhledávání: '"Sriram Venigalla"'
Autor:
Varsha Jain, Sriram Venigalla, Ronnie A. Sebro, Giorgos C. Karakousis, Robert J. Wilson II, Kristy L. Weber, Jacob E. Shabason
Publikováno v:
Cancer Medicine, Vol 8, Iss 14, Pp 6295-6304 (2019)
Abstract Background Numerous studies across a variety of malignancies have demonstrated that health insurance status is associated with differences in clinical presentation, type of treatments received, and survival. The effect of insurance status on
Externí odkaz:
https://doaj.org/article/979d491480c146b493cab08c69966e61
Autor:
Yubing Tong, PhD, Jayaram K. Udupa, PhD, FIEEE, FAIMBE, Chuang Wang, PhD, Jerry Chen, MD, Sriram Venigalla, MD, Thomas J. Guzzo, MD, Ronac Mamtani, MD, Brian C. Baumann, MD, John P. Christodouleas, MD, Drew A. Torigian, MD, MA, FSAR
Publikováno v:
Advances in Radiation Oncology, Vol 3, Iss 3, Pp 331-338 (2018)
Background: Current clinical staging methods are unable to accurately define the extent of invasion of localized bladder cancer, which affects the proper use of systemic therapy, surgery, and radiation. Our purpose was to test a novel radiomics appro
Externí odkaz:
https://doaj.org/article/7bb80ee3787446c893727b88a1b83f37
Autor:
Joshua Jones, Ima Paydar, Antony I. Koroulakis, G. Kurtz, John P. Plastaras, Jonathan Baron, Elise A. Chong, Yolanda D. Tseng, Amit Maity, Sriram Venigalla, Christopher M. Wright, Michael J. LaRiviere, Pranshu Mohindra
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 21:650-658
Recent improvements in chemoimmunotherapies, targeted agents, hematopoietic stem cell transplants, and cellular therapies have revolutionized treatment paradigms for patients with diffuse large B-cell lymphoma (DLBCL). Even in the relapsed or refract
Autor:
Kristy L. Weber, Jacob E. Shabason, William P. Levin, Ronnie Sebro, Varsha Jain, Vishruth K. Reddy, Robert J. Wilson, Anusha Kalbasi, Sriram Venigalla
Publikováno v:
Journal of the National Comprehensive Cancer Network. 19:295-306
Background: Practice patterns of radiation therapy (RT) use for soft-tissue sarcoma (STS) remain quite variable, despite clinical practice guidelines recommending the addition of RT to surgery for patients with high-grade STS, particularly for larger
Autor:
Charles B. Simone, William D. Lindsay, Vivek Verma, Surbhi Grover, Emily J. Anstadt, Christopher A. Ahern, Andrew R. Barsky, Keith A. Cengel, Sriram Venigalla, Christopher M. Wright, Ethan B. Ludmir, Christopher G. Berlind
Publikováno v:
Clinical Lung Cancer. 21:e583-e591
Background Despite accounting for a minority of malignant pleural mesothelioma (MPM) diagnoses, females may experience differential survival relative to males. It is unclear if there are gender-based differences in receipt of treatment or disease-rel
Autor:
Ethan B. Ludmir, Charles B. Simone, Surbhi Grover, Vivek Verma, Christopher A. Ahern, William D. Lindsay, Sriram Venigalla, Christopher M. Wright, Emily J. Anstadt, Keith A. Cengel, Christopher G. Berlind, Andrew R. Barsky
Publikováno v:
Journal of the National Comprehensive Cancer Network. 18:CLO20-030
Autor:
Stuti Shroff, Major K. Lee, James M. Metz, Edgar Ben-Josef, Ursina R. Teitelbaum, Kim A. Reiss, William Tristram Arscott, Kevin T. Nead, Mark H. O'Hara, John N. Lukens, Andrzej P. Wojcieszynski, Jacob E. Shabason, Jeffrey A. Drebin, Sriram Venigalla, Adham S. Bear, John P. Plastaras, Arturo Loaiza-Bonilla
Publikováno v:
American Journal of Clinical Oncology
Purpose: This study evaluates the toxicity and tumor response with concurrent nab-paclitaxel chemoradiotherapy (CRT) compared with standard (5-fluorouracil or gemcitabine) CRT. Materials and Methods: Fifty patients with borderline resectable or unres
Autor:
Vishruth K. Reddy, Varsha Jain, Sriram Venigalla, Jacob E. Shabason, Tara C. Mitchell, John N. Lukens
Publikováno v:
Journal of Immunotherapy. 43:8-15
The effect of health insurance on management and outcomes in melanoma is unclear. Using the National Cancer Database (NCDB), we evaluated the effect of insurance on (1) stage at diagnosis, (2) receipt of immunotherapy, and (3) overall survival (OS) a
Autor:
Jacob E. Shabason, Tara C. Mitchell, Kevin T. Nead, John N. Lukens, Sriram Venigalla, Wei-Ting Hwang, Varsha Jain
Publikováno v:
Journal of Immunological Sciences. 3:1-7
Publikováno v:
Brachytherapy. 18:322-331
Retrospective data suggest less benefit from androgen deprivation therapy (ADT) in the setting of dose-escalated definitive radiation for prostate cancer, especially when a combination of external beam radiotherapy (EBRT) and brachytherapy approaches